| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.073 | 0.1 |
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | 0.054 | 0.2 |
| mRNA | BRD-K90370028 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.2 |
| mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.2 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | 0.054 | 0.2 |
| mRNA | TAK-715 | GDSC1000 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.052 | 0.2 |
| mRNA | BIX02189 | GDSC1000 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | 0.045 | 0.2 |